Melanocortin Receptor Pharmacology: Research Applications of MC1R and MC4R Agonists

The melanocortin receptor family comprises five G protein-coupled receptor subtypes (MC1R through MC5R) with distinct tissue distributions and functional roles. As research targets, these receptors have attracted significant interest across multiple fields including pigmentation biology, energy homeostasis research, neuroendocrinology, and CNS pharmacology.

MC1R, expressed primarily in melanocytes, governs pigmentation responses and has been studied extensively in skin biology and photoprotection research. MC4R, expressed in the hypothalamus and limbic system, plays roles in energy balance and neuroendocrine regulation, making it a target of interest in metabolic and CNS research. The distinct pharmacological profiles of these receptor subtypes create opportunities for selective tool compound development.

Bremelanotide (PT-141) is a melanocortin receptor agonist with activity at multiple receptor subtypes, including MC1R and MC4R. In laboratory research settings, it serves as a tool compound for studying melanocortin receptor binding kinetics, downstream cAMP signaling, and the comparative pharmacology of melanocortin receptor subtypes. Researchers use it in cell-based assays to investigate receptor activation mechanisms and structure-activity relationships within the melanocortin peptide family.

The receptor selectivity profile of melanocortin agonists is a subject of active research interest. Understanding the structural determinants that govern selectivity between MC1R, MC3R, MC4R, and MC5R is relevant to the development of more targeted research tools and the investigation of receptor subtype-specific signaling pathways.

All melanocortin receptor agonist peptides supplied by our laboratory are intended exclusively for in vitro research use. They are not for human or veterinary administration. Researchers are responsible for ensuring that their use of these compounds complies with all applicable institutional biosafety protocols, ethical review requirements, and regulatory frameworks.